PubMed

Measurement of self-reported HIV risk behaviors in injection drug users: Comparison of standard versus timeline follow-back administration procedures.

Copersino ML, Meade CS, Bigelow GE, Brooner RK.

J Subst Abuse Treat. 2009 Aug 28. [Epub ahead of print]PMID: 19717270 [PubMed - as supplied by publisher]Related articles

Cocaine abuse versus cocaine dependence: Cocaine self-administration and pharmacodynamic response in the human laboratory.

Walsh SL, Donny EC, Nuzzo PA, Umbricht A, Bigelow GE.

Drug Alcohol Depend. 2009 Aug 28. [Epub ahead of print]PMID: 19717246 [PubMed - as supplied by publisher]Related articles

Repeated dosing with oral cocaine in humans: assessment of direct effects, withdrawal, and pharmacokinetics.

Walsh SL, Stoops WW, Moody DE, Lin SN, Bigelow GE.

Exp Clin Psychopharmacol. 2009 Aug;17(4):205-16.PMID: 19653786 [PubMed - indexed for MEDLINE]Related articles

Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument.

Tompkins DA, Bigelow GE, Harrison JA, Johnson RE, Fudala PJ, Strain EC.

Drug Alcohol Depend. 2009 Nov 1;105(1-2):154-9. Epub 2009 Aug 3.PMID: 19647958 [PubMed - in process]Related articles

Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with fosamprenavir-ritonavir in opioid-dependent subjects.

Cao YJ, Smith PF, Wire MB, Lou Y, Lancaster CT, Causon RC, Bigelow GE, Martinez E, Fuchs EJ, Radebaugh C, McCabe S, Hendrix CW.

Pharmacotherapy. 2008 Jul;28(7):863-74.PMID: 18576901 [PubMed - indexed for MEDLINE]Related articles

Opioid detoxification via single 7-day application of a buprenorphine transdermal patch: an open-label evaluation.

Lanier RK, Umbricht A, Harrison JA, Nuwayser ES, Bigelow GE.

Psychopharmacology (Berl). 2008 Jun;198(2):149-58. Epub 2008 Mar 9.PMID: 18327673 [PubMed - indexed for MEDLINE]Related articles

QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.

Wedam EF, Bigelow GE, Johnson RE, Nuzzo PA, Haigney MC.

Arch Intern Med. 2007 Dec 10;167(22):2469-75.PMID: 18071169 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade.

Walsh SL, Chausmer AE, Strain EC, Bigelow GE.

Psychopharmacology (Berl). 2008 Jan;196(1):143-55. Epub 2007 Oct 2.PMID: 17909753 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of a transdermal buprenorphine formulation in opioid detoxification.

Lanier RK, Umbricht A, Harrison JA, Nuwayser ES, Bigelow GE.

Addiction. 2007 Oct;102(10):1648-56.PMID: 17854341 [PubMed - indexed for MEDLINE]Related articles

Contingency management in cocaine abusers: a dose-effect comparison of goods-based versus cash-based incentives.

Vandrey R, Bigelow GE, Stitzer ML.

Exp Clin Psychopharmacol. 2007 Aug;15(4):338-43.PMID: 17696680 [PubMed - indexed for MEDLINE]Related articlesFree article

Experimentally-induced spontaneous opiate withdrawal: relationship to cigarette craving and expired air carbon monoxide.

Lofwall MR, Walsh SL, Bigelow GE, Strain EC.

Am J Addict. 2007 Jul-Aug;16(4):310-5.PMID: 17661199 [PubMed - indexed for MEDLINE]Related articles

Modest opioid withdrawal suppression efficacy of oral tramadol in humans.

Lofwall MR, Walsh SL, Bigelow GE, Strain EC.

Psychopharmacology (Berl). 2007 Oct;194(3):381-93. Epub 2007 Jul 1.PMID: 17605004 [PubMed - indexed for MEDLINE]Related articles

Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone.

Rosado J, Walsh SL, Bigelow GE, Strain EC.

Drug Alcohol Depend. 2007 Oct 8;90(2-3):261-9. Epub 2007 May 22.PMID: 17517480 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period.

Correia CJ, Walsh SL, Bigelow GE, Strain EC.

Psychopharmacology (Berl). 2006 Dec;189(3):297-306. Epub 2006 Sep 30.PMID: 17013637 [PubMed - indexed for MEDLINE]Related articles

HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone.

Lott DC, Strain EC, Brooner RK, Bigelow GE, Johnson RE.

J Subst Abuse Treat. 2006 Sep;31(2):187-94. Epub 2006 Jul 18. Erratum in: J Subst Abuse Treat. 2006 Oct;31(3):317. PMID: 16919747 [PubMed - indexed for MEDLINE]Related articles

Assessment of agonist and antagonist effects of tramadol in opioid-dependent humans.

Carroll CP, Walsh SL, Bigelow GE, Strain EC, Preston KL.

Exp Clin Psychopharmacol. 2006 May;14(2):109-20.PMID: 16756415 [PubMed - indexed for MEDLINE]Related articles

Comparing the physiological and subjective effects of self-administered vs yoked cocaine in humans.

Donny EC, Bigelow GE, Walsh SL.

Psychopharmacology (Berl). 2006 Jul;186(4):544-52. Epub 2006 Mar 21.PMID: 16552557 [PubMed - indexed for MEDLINE]Related articles

An injection depot formulation of buprenorphine: extended bio-delivery and effects.

Sigmon SC, Moody DE, Nuwayser ES, Bigelow GE.

Addiction. 2006 Mar;101(3):420-32.PMID: 16499515 [PubMed - indexed for MEDLINE]Related articles

Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence.

Marsch LA, Stephens MA, Mudric T, Strain EC, Bigelow GE, Johnson RE.

Exp Clin Psychopharmacol. 2005 Nov;13(4):293-302.PMID: 16366759 [PubMed - indexed for MEDLINE]Related articles

Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.

Donny EC, Brasser SM, Bigelow GE, Stitzer ML, Walsh SL.

Addiction. 2005 Oct;100(10):1496-509.PMID: 16185211 [PubMed - indexed for MEDLINE]Related articles

Characteristics of older opioid maintenance patients.

Lofwall MR, Brooner RK, Bigelow GE, Kindbom K, Strain EC.

J Subst Abuse Treat. 2005 Apr;28(3):265-72.PMID: 15857727 [PubMed - indexed for MEDLINE]Related articles

Safety and efficacy of L-tryptophan and behavioral incentives for treatment of cocaine dependence: a randomized clinical trial.

Jones HE, Johnson RE, Bigelow GE, Silverman K, Mudric T, Strain EC.

Am J Addict. 2004 Oct-Dec;13(5):421-37.PMID: 15764421 [PubMed - indexed for MEDLINE]Related articles

Behavioral contingencies improve counseling attendance in an adaptive treatment model.

Brooner RK, Kidorf MS, King VL, Stoller KB, Peirce JM, Bigelow GE, Kolodner K.

J Subst Abuse Treat. 2004 Oct;27(3):223-32.PMID: 15501375 [PubMed - indexed for MEDLINE]Related articles

Evaluation of an injection depot formulation of buprenorphine: placebo comparison.

Sigmon SC, Wong CJ, Chausmer AL, Liebson IA, Bigelow GE.

Addiction. 2004 Nov;99(11):1439-49.PMID: 15500597 [PubMed - indexed for MEDLINE]Related articles

A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs.

Silverman K, Robles E, Mudric T, Bigelow GE, Stitzer ML.

J Consult Clin Psychol. 2004 Oct;72(5):839-54.PMID: 15482042 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with amprenavir in opioid-dependent subjects.

Hendrix CW, Wakeford J, Wire MB, Lou Y, Bigelow GE, Martinez E, Christopher J, Fuchs EJ, Snidow JW.

Pharmacotherapy. 2004 Sep;24(9):1110-21.PMID: 15460171 [PubMed - indexed for MEDLINE]Related articles

Relative bioavailability of different buprenorphine formulations under chronic dosing conditions.

Strain EC, Moody DE, Stoller KB, Walsh SL, Bigelow GE.

Drug Alcohol Depend. 2004 Apr 9;74(1):37-43.PMID: 15072805 [PubMed - indexed for MEDLINE]Related articles

Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification.

Sobel BF, Sigmon SC, Walsh SL, Johnson RE, Liebson IA, Nuwayser ES, Kerrigan JH, Bigelow GE.

Drug Alcohol Depend. 2004 Jan 7;73(1):11-22.PMID: 14687955 [PubMed - indexed for MEDLINE]Related articles

Assessing the initiation of cocaine self-administration in humans during abstinence: effects of dose, alternative reinforcement, and priming.

Donny EC, Bigelow GE, Walsh SL.

Psychopharmacology (Berl). 2004 Mar;172(3):316-23. Epub 2003 Nov 28.PMID: 14647955 [PubMed - indexed for MEDLINE]Related articles

Transdermal selegiline and intravenous cocaine: safety and interactions.

Houtsmuller EJ, Notes LD, Newton T, van Sluis N, Chiang N, Elkashef A, Bigelow GE.

Psychopharmacology (Berl). 2004 Feb;172(1):31-40. Epub 2003 Nov 6.PMID: 14605792 [PubMed - indexed for MEDLINE]Related articles

Principles of initial experimental drug abuse liability assessment in humans.

Griffiths RR, Bigelow GE, Ator NA.

Drug Alcohol Depend. 2003 Jun 5;70(3 Suppl):S41-54. Review.PMID: 12759196 [PubMed - indexed for MEDLINE]Related articles

Guidelines and methodological reviews concerning drug abuse liability assessment.

Balster RL, Bigelow GE.

Drug Alcohol Depend. 2003 Jun 5;70(3 Suppl):S13-40. Review.PMID: 12759195 [PubMed - indexed for MEDLINE]Related articles

Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans.

Walsh SL, Strain EC, Bigelow GE.

Addiction. 2003 Apr;98(4):427-39.PMID: 12653813 [PubMed - indexed for MEDLINE]Related articles

Choosing to take cocaine in the human laboratory: effects of cocaine dose, inter-choice interval, and magnitude of alternative reinforcement.

Donny EC, Bigelow GE, Walsh SL.

Drug Alcohol Depend. 2003 Apr 1;69(3):289-301.PMID: 12633915 [PubMed - indexed for MEDLINE]Related articles

A reinforcement-based therapeutic workplace for the treatment of drug abuse: three-year abstinence outcomes.

Silverman K, Svikis D, Wong CJ, Hampton J, Stitzer ML, Bigelow GE.

Exp Clin Psychopharmacol. 2002 Aug;10(3):228-40.PMID: 12233983 [PubMed - indexed for MEDLINE]Related articles

High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.

Donny EC, Walsh SL, Bigelow GE, Eissenberg T, Stitzer ML.

Psychopharmacology (Berl). 2002 May;161(2):202-12. Epub 2002 Mar 13.PMID: 11981600 [PubMed - indexed for MEDLINE]Related articles

Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine.

Strain EC, Walsh SL, Bigelow GE.

Psychopharmacology (Berl). 2002 Jan;159(2):161-6. Epub 2001 Oct 12.PMID: 11862344 [PubMed - indexed for MEDLINE]Related articles

Voucher-based reinforcement of opiate abstinence during methadone detoxification.

Robles E, Stitzer ML, Strain EC, Bigelow GE, Silverman K.

Drug Alcohol Depend. 2002 Jan 1;65(2):179-89.PMID: 11772479 [PubMed - indexed for MEDLINE]Related articles

Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans.

Evans SM, Walsh SL, Levin FR, Foltin RW, Fischman MW, Bigelow GE.

Drug Alcohol Depend. 2001 Nov 1;64(3):271-83.PMID: 11672942 [PubMed - indexed for MEDLINE]Related articles

A validated liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry method for quantitation of cocaine and benzoylecgonine in human plasma.

Lin SN, Moody DE, Bigelow GE, Foltz RL.

J Anal Toxicol. 2001 Oct;25(7):497-503.PMID: 11599591 [PubMed - indexed for MEDLINE]Related articles

Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans.

Walsh SL, Strain EC, Abreu ME, Bigelow GE.

Psychopharmacology (Berl). 2001 Sep;157(2):151-62.PMID: 11594439 [PubMed - indexed for MEDLINE]Related articles

Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans.

Walsh SL, Geter-Douglas B, Strain EC, Bigelow GE.

J Pharmacol Exp Ther. 2001 Oct;299(1):147-58.PMID: 11561074 [PubMed - indexed for MEDLINE]Related articlesFree article

Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude.

Dallery J, Silverman K, Chutuape MA, Bigelow GE, Stitzer ML.

Exp Clin Psychopharmacol. 2001 Aug;9(3):317-25.PMID: 11534542 [PubMed - indexed for MEDLINE]Related articles

A reinforcement-based therapeutic workplace for the treatment of drug abuse: six-month abstinence outcomes.

Silverman K, Svikis D, Robles E, Stitzer ML, Bigelow GE.

Exp Clin Psychopharmacol. 2001 Feb;9(1):14-23.PMID: 11519628 [PubMed - indexed for MEDLINE]Related articles

Gradual dose taper following chronic buprenorphine.

Becker AB, Strain EC, Bigelow GE, Stitzer ML, Johnson RE.

Am J Addict. 2001 Spring;10(2):111-21.PMID: 11444154 [PubMed - indexed for MEDLINE]Related articles

Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine.

Nann-Vernotica E, Donny EC, Bigelow GE, Walsh SL.

Psychopharmacology (Berl). 2001 Jun;155(4):338-47.PMID: 11441423 [PubMed - indexed for MEDLINE]Related articles

Effects of buprenorphine/naloxone in opioid-dependent humans.

Stoller KB, Bigelow GE, Walsh SL, Strain EC.

Psychopharmacology (Berl). 2001 Mar;154(3):230-42.PMID: 11351930 [PubMed - indexed for MEDLINE]Related articles

Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans.

Abreu ME, Bigelow GE, Fleisher L, Walsh SL.

Psychopharmacology (Berl). 2001 Feb;154(1):76-84.PMID: 11292009 [PubMed - indexed for MEDLINE]Related articles

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.

Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE.

N Engl J Med. 2000 Nov 2;343(18):1290-7.PMID: 11058673 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of agonist-antagonist opioids in humans trained in a hydromorphone/not hydromorphone discrimination.

Preston KL, Bigelow GE.

J Pharmacol Exp Ther. 2000 Oct;295(1):114-24.PMID: 10991968 [PubMed - indexed for MEDLINE]Related articlesFree article